Sangamo Therapeutics, Inc. (SGMO) SEC filings
SGMO SEC filings moved a median of -1.50% by the close. SGMO SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the SGMO overview →
58 measured SGMO SEC filing events.
Where these SGMO SEC filings landedvs 56 measured SGMO SEC filing reactions
| Middle 50% of SGMO SEC filing reactions | -6.92% to +5.92% |
|---|---|
| Median reaction (to close) | -1.50% |
| Measured reactions | 56 |
Point-in-time · zero look-ahead
Half of the 56 SGMO SEC filing events with a measured close landed between -6.92% and +5.92%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K SANGAMO THERAPEUTICS, For: Jun 24 | SEC filing · Form 8-K | — | — | |
| Form 8-K SANGAMO THERAPEUTICS, For: Jun 18 | SEC filing · Form 8-K | +4.68% | -3.77% | |
| Form 8-K/A SANGAMO THERAPEUTICS, For: Jun 18 | SEC filing · Form 8-K | — | — | |
| Form 10-Q SANGAMO THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +3.85% | |
| Form 8-K SANGAMO THERAPEUTICS, For: May 14 | SEC filing · Form 8-K | +0.00% | +3.85% | |
| Form 10-K/A SANGAMO THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | -1.17% | -6.88% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Apr 28 | SEC filing · Form 8-K | +4.02% | +8.85% | |
| Form 10-K SANGAMO THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | -1.44% | +7.35% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Mar 30 | SEC filing · Form 8-K | -1.44% | +7.35% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Feb 03 | SEC filing · Form 8-K | -4.09% | -13.35% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Feb 02 | SEC filing · Form 8-K | +1.34% | -14.08% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Feb 03 | SEC filing · Form 8-K | -4.09% | -13.35% | |
| Form 10-Q SANGAMO THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | +11.93% | +9.64% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Nov 06 | SEC filing · Form 8-K | +11.93% | +9.64% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Oct 29 | SEC filing · Form 8-K | +0.57% | +0.17% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Sep 24 | SEC filing · Form 8-K | +1.38% | +1.28% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Sep 09 | SEC filing · Form 8-K | +0.02% | -4.74% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Sep 04 | SEC filing · Form 8-K | -3.72% | +2.12% | |
| Form S-8 SANGAMO THERAPEUTICS, | SEC filing · Form S-8 | +0.45% | -4.92% | |
| Form 10-Q SANGAMO THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | -5.31% | +1.53% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Aug 07 | SEC filing · Form 8-K | -5.31% | +1.53% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Jun 24 | SEC filing · Form 8-K | +2.79% | +13.57% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Jun 12 | SEC filing · Form 8-K | -1.72% | -3.38% | |
| Form 8-K SANGAMO THERAPEUTICS, For: May 12 | SEC filing · Form 8-K | -2.70% | -11.80% | |
| Form 10-Q SANGAMO THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | -6.33% | -2.95% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Apr 30 | SEC filing · Form 8-K | -2.51% | +3.44% | |
| Form ARS SANGAMO THERAPEUTICS, For: Dec 31 | SEC filing · Form ARS | -2.36% | +8.39% | |
| Form DEF 14A SANGAMO THERAPEUTICS, For: Jun 12 | SEC filing · Form DEF | -2.36% | +8.39% | |
| Form 10-K SANGAMO THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | -1.00% | -6.92% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Mar 17 | SEC filing · Form 8-K | -1.00% | -6.92% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Feb 06 | SEC filing · Form 8-K | -2.52% | -8.63% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Dec 22 | SEC filing · Form 8-K | +2.79% | -4.67% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Dec 09 | SEC filing · Form 8-K | -1.50% | -2.50% | |
| Form EFFECT SANGAMO THERAPEUTICS, | SEC filing · Form EFFECT | -3.15% | -5.34% | |
| Form 10-Q SANGAMO THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | +13.34% | +8.44% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Nov 12 | SEC filing · Form 8-K | +13.34% | +8.44% | |
| Form S-3 SANGAMO THERAPEUTICS, | SEC filing · Form S-3 | +13.34% | +8.44% | |
| Form S-8 SANGAMO THERAPEUTICS, | SEC filing · Form S-8 | +13.34% | +8.44% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Oct 04 | SEC filing · Form 8-K | -0.18% | +4.29% | |
| Form 10-Q SANGAMO THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | -4.04% | -13.44% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Aug 06 | SEC filing · Form 8-K | -4.04% | -13.44% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Jul 24 | SEC filing · Form 8-K | +5.62% | +30.41% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Jun 04 | SEC filing · Form 8-K | +1.00% | +2.16% | |
| Form 10-Q SANGAMO THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | -0.66% | +5.92% | |
| Form 8-K SANGAMO THERAPEUTICS, For: May 09 | SEC filing · Form 8-K | -0.66% | +5.92% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Apr 24 | SEC filing · Form 8-K | -0.92% | +3.84% | |
| Form ARS SANGAMO THERAPEUTICS, For: Dec 31 | SEC filing · Form ARS | +3.66% | -3.85% | |
| Form DEF 14A SANGAMO THERAPEUTICS, For: Jun 04 | SEC filing · Form DEF | +3.66% | -3.85% | |
| Form PRE 14A SANGAMO THERAPEUTICS, For: Jun 04 | SEC filing · Form PRE | +0.12% | -4.26% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Mar 21 | SEC filing · Form 8-K | -3.21% | -8.74% | |
| Form 10-K SANGAMO THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | -1.74% | -10.78% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Mar 13 | SEC filing · Form 8-K | -1.74% | -10.78% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Feb 05 | SEC filing · Form 8-K | +0.02% | -8.55% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Jan 19 | SEC filing · Form 8-K | -2.27% | +3.34% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Dec 11 | SEC filing · Form 8-K | +0.39% | -0.50% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Nov 02 | SEC filing · Form 8-K | -1.48% | -2.94% | |
| Form 10-Q SANGAMO THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | -2.66% | -15.52% | |
| Form 8-K SANGAMO THERAPEUTICS, For: Nov 01 | SEC filing · Form 8-K | -2.66% | -15.52% |
Keep exploring
More SGMO: earnings → · analyst actions → · SGMO overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| EIDOS THERAPEUTICS (EIDX) | 300 | +0.01% | 51% |
| Grifols, S.A. - American Depositary Shares (GRFS) | 300 | -0.13% | 39% |
| Merit Medical Systems, Inc. (MMSI) | 299 | -0.03% | 48% |
| PLx Pharma Inc. (PLXP) | 299 | -0.05% | 35% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.